1 Min Read
May 30 (Reuters) - ALMIRALL SA:
* ALMIRALL AND LEO PHARMA TO COLLABORATE ON DEVELOPING AND CLINICALLY VALIDATING MINIMALLY INVASIVE SKIN SAMPLING METHOD Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.